Disease | congestive heart failure |
Phenotype | C0006142|breast cancer |
Sentences | 2 |
PubMedID- 25096848 | Background and objective: congestive heart failure (chf) risk with bevacizumab in breast cancer has been previously investigated in a meta-analysis, but its incidence and the risk of chf in other tumor types remain unclear. |
PubMedID- 21205755 | congestive heart failure risk in patients with breast cancer treated with bevacizumab. |
Page: 1